National Center for Health Research: The Voice For Prevention, Treatment, and Policy
Wendy Dolin, (founder) was asked to participate in the June 2014 National Center For Health Research Conference in Washington, DC. The objective for this workshop (which was led by 10 patient and consumer advocates) is to learn about the scientific evidence perspectives that the FDA then considers when making decisions to approve or recall a medical product. Wendy Dolin was one of the participants on this panel.
Below are some excerpts from an article summarizing the conference, with MISSD founder Wendy Dolin featured in one of the photos:
Chantix Video Presented At FDA Advisory Committee
Pfizer has recently presented Chantix to the FDA in efforts to remove the black box warning (although side effects of this drug are very serious and have lead to suicidal behavior). Chantix did NOT lose the black box warning, but here is a powerful video discussing some of the side effects of this drug.
One Dose of Antidepressant Changes Brain Connections, Study Says
“Experts said the hope is to eventually be able to predict which people with depression are likely to benefit from a drug — and which people would fare better with a different option.”
-Norton, A.; HealthDay News 9/18/2014
MISSD Supports Suicide Prevention at the 2014 Out of the Darkness Walk
September marks Suicide Awareness Month and the MISSD Team will once again be participating in the Out of the Darkness Chicago Walk, put on by the American Foundation for Suicide Prevention (AFSP)! The walk will take place at Grant Park on Saturday, September 20th, 2014! We are looking forward to raising more awareness about our organization and supporting other suicide prevention related organizations. For more information about this walk, you can visit http://afsp.donordrive.com/index.cfm?fuseaction=donorDrive.event&eventID=2579.
MISSD Holds 2ND Annual Fundraising Event
September marks Suicide Awareness Month and The Medication-Induced Suicide Education Foundation in Memory of Stewart Dolin (MISSD) will hold its 2nd Annual Fundraising Event.
The event is on Thursday, September 4, 2014, from 6:30 pm- 9:30 pm, at Park West, 322 West Armitage Avenue, Chicago, Illinois. The evening will be educational, but fun-filled with appetizers, cocktails and raffles. Tickets are $50 (35 years and under) or $125 (36 years and over). To purchase tickets please go to missd.eventbrite.com.
Two years ago, MISSD was founded in Stewart Dolin’s memory to raise awareness and educate the public about the dangers of medication-induced suicide and akathisia. MISSD is not an anti-drug organization, rather we look to raise awareness about potential side effects and better monitoring of patients who have recently started or stopped a medication, specifically a Selective Serotonin Reuptake Inhibitor (SSRI) medication.
MISSD has made many strides towards reaching these objectives by reaching out to the public by attending and participating in related conferences and walks, developing a brochure and more. We are in the midst of putting together an educational presentation to present at schools, hospitals, and other related venues.
To learn more about our organization, please visit www.missd.co.
MISSD Founder featured on NBC Chicago!
On May 27, 2014, MISSD founder Wendy Dolin was featured on NBC Chicago, discussing akathisia and generic drugs:
“Drug Company Consultants ‘Explain’ Military Suicides… Kind Of” By Martha Rosenberg
This article reflects upon the increase of military suicides. It states that 30% of military personnel who kill themselves have never been deployed and that 60% have not seen combat. This gives some leading suspicion that the excessive drug distribution to military personnel is what is in fact causing these suicides.